6 results
6-K
EX-99.1
SNY
Sanofi
25 Apr 24
Sales growth of 6.7% at CER and business EPS(1) of €1.78
10:49am
and will have access to a network of volunteer colleagues trained to help them navigate from initial diagnosis through the treatment journey and return to work … which allows them to carry out caregiving duties for their close family member suffering from a critical illness1.
In 2017, several volunteer
6-K
EX-99.1
SNY
Sanofi
15 Feb 24
Current report (foreign)
12:09pm
by cancer and other critical illnesses. They will have access to a network of volunteer colleagues trained to help them navigate from initial diagnosis … a colleague navigate their local benefit and support programs.
A global program inspired by an employee initiative
In 2017, several volunteer
SC TO-C
EX-99.2
SNY
Sanofi
18 Aug 20
Information about tender offer
12:00am
1 healthy volunteer study completed 2019: Phase 2b dose-finding study starts 2020: Phase 2b dose-finding study read-out, Phase 3 program starts
6-K
EX-99.3
SNY
Sanofi
24 Jun 20
R&D strategy driving pipeline momentum, productivity and innovation
3:08pm
in healthy volunteer participants.
Low overall median ABR of 0.84. The median ABR in thenon-inhibitor subgroup was 1.01 compared topre-study median
SC TO-T
EX-99
SNY
Sanofi
11 Jan 10
Third party tender offer statement
12:00am
.
Facsimile: + 1 (212) 735-2000
Miller & Martin PLLC
832 Georgia Avenue
Suite 1000, Volunteer Building
Chattanooga, TN 37402
USA
Attention: Hugh
6-K
EX-99.1
m3s3e28g2vf9n2dc ayp
11 May 06
Current report (foreign)
12:00am
- Prev
- 1
- Next